Table 2 Univariate analysis for factors predicting major complications related to gastric conduit after TE

Age (years)

62.9 ± 7.2

57.5 ± 8.7

<  0.01

Gender (Male, Female)

37, 15

20, 3

N.S.

BMI

21.4 ± 2.7

21.1 ± 2.7

N.S.

Preoperative chemotherapy

21 (40.4%)

13 (56.5%)

N.S.

TNM Stage (I, II, III, IV)

22, 10, 18, 2

6, 9, 6, 2

N.S.

Total operation time (min)

604 ± 113

606 ± 116

N.S.

Operation time of thoracic surgery (min)

337 ± 77

318 ± 64

N.S.

Blood loss (g)

380 (303–623)

340 (200–500)

N.S.

Blood Transfusion

5 (9.6%)

2 (5.2%)

N.S.

3-field lymph node dissection

12 (23.1%)

11 (47.8%)

0.03

Paroxysmal atrial fibrillation

10 (19.2%)

3 (13.0%)

N.S.

Vasopressor agents

5 (9.6%)

3 (13.0%)

N.S.

WBC (10^3/μl) at 1POD

9.7 (8.2–12.8)

8.9 (7.0–11.5)

N.S.

CRP (10^4 μg/L) at 1POD

8.7 ± 0.3

10.3 ± 0.5

<  0.01

Lactic acid (mmol/L) at 1POD

1.4 (1.1–1,8)

2.1 (1.2–2.7)

N.S.

CPK (IU/L) at 1POD

890 (620–1309)

1277 (675–2041)

0.02

Postoperative hospital stay (days)

22 (19–28)

39 (28–47)

<  0.01